Partners Innovation Fund logo

Partners Innovation Fund

North America, Massachusetts, United States, Boston

Description

Partners Innovation Fund provides the necessary support to advance innovations in medical systems, therapy, drugs and medical devices.

Investor Profile

Partners Innovation Fund has made 47 investments, with 0 in the past 12 months and 6% as lead.

Stage Focus

  • Series A (60%)
  • Series B (19%)
  • Seed (6%)
  • Series C (4%)
  • Series D (4%)
  • Series Unknown (4%)
  • Debt Financing (2%)

Country Focus

  • United States (96%)
  • France (2%)
  • United Kingdom (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Medical Device
  • Health Diagnostics
  • Genetics
  • Information Technology
  • Emergency Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Partners Innovation Fund frequently co-invest with?

Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 3
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 4
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 3
Baxalta Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 15
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
AB
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 3
Apple Tree Partners
North America, New York, United States, New York
Co-Investments: 4
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 4
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 3

Which angels does Partners Innovation Fund often collaborate with?

HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1

What are some of recent deals done by Partners Innovation Fund?

Pykus Therapeutics

Boston, Massachusetts, United States

Pykus Therapeutics are develop a dissolvable intraocular surgical device to make retinal surgery less painful and more successful.

Health CareMedicalTherapeutics
Series UnknownFeb 4, 2021
Amount Raised: $2,487,307
Verve Therapeutics

Boston, Massachusetts, United States

Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.

BiotechnologyGeneticsLife Science
Series AJun 11, 2020
Amount Raised: $63,000,000
ROME Therapeutics

Cambridge, Massachusetts, United States

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

BiotechnologyHealth CarePharmaceutical
Series AApr 27, 2020
Amount Raised: $50,000,000
SwanBio Therapeutics

Bala Cynwyd, Pennsylvania, United States

SwanBio Therapeutics is a gene therapy company focused on the development and commercialisation of genetically defined therapies.

Biotechnology
Series AApr 23, 2020
Amount Raised: $52,000,000
Affinia Therapeutics

Waltham, Massachusetts, United States

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.

BiotechnologyHealth CareLife ScienceTherapeutics
Series AMar 31, 2020
Amount Raised: $60,000,000
Keros Therapeutics

Lexington, Massachusetts, United States

Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CMar 4, 2020
Amount Raised: $56,000,000
Akouos

Boston, Massachusetts, United States

Akouos is a biotechnology company focusing on restoring and preserving hearing.

BiotechnologyHealth DiagnosticsPharmaceutical
Series BMar 3, 2020
Amount Raised: $105,000,000
Triplet Therapeutics

Cambridge, Massachusetts, United States

Triplet is developing transformative therapies that treat repeat expansion disorders at their source.

BiotechnologyHealth Care
Series ADec 17, 2019
Amount Raised: $49,000,000
ZielBio

Charlottesville, Virginia, United States

ZielBio is an early-stage biotechnology company that identifies novel high value disease targets.

BiotechnologyHealth CareTherapeutics
Series ASep 26, 2019
Amount Raised: $25,100,000
Amolyt Pharma

Écully, Rhone-Alpes, France

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

BiotechnologyHealth CareMedicalPharmaceuticalWellness
Series AJul 31, 2019
Amount Raised: $74,180,691